Assessment of MGMT methylation status using high-performance liquid chromatography in newly diagnosed glioblastoma
出版年份 2020 全文链接
标题
Assessment of MGMT methylation status using high-performance liquid chromatography in newly diagnosed glioblastoma
作者
关键词
-
出版物
Clinical Epigenetics
Volume 12, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-11-18
DOI
10.1186/s13148-020-00968-5
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Association of aberrant ASNS imprinting with asparaginase sensitivity and chromosomal abnormality in childhood BCP-ALL
- (2020) Atsushi Watanabe et al. BLOOD
- Novel predictive epigenetic signature for temozolomide in non-G-CIMP glioblastomas
- (2019) An-An Yin et al. Clinical Epigenetics
- Novel method for DNA methylation analysis using high-performance liquid chromatography and its clinical application
- (2018) Takuya Yotani et al. CANCER SCIENCE
- MGMT promoter methylation in patients with glioblastoma: is methylation-sensitive high-resolution melting superior to methylation-sensitive polymerase chain reaction assay?
- (2018) Shinji Yamashita et al. JOURNAL OF NEUROSURGERY
- Association of MGMT Promoter Methylation Status With Survival Outcomes in Patients With High-Risk Glioma Treated With Radiotherapy and Temozolomide
- (2018) Erica H. Bell et al. JAMA Oncology
- The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
- (2016) David N. Louis et al. ACTA NEUROPATHOLOGICA
- Validation of the high-performance of pyrosequencing for clinical MGMT testing on a cohort of glioblastoma patients from a prospective dedicated multicentric trial
- (2016) Véronique Quillien et al. Oncotarget
- MGMT Promoter Methylation Is a Strong Prognostic Biomarker for Benefit from Dose-Intensified Temozolomide Rechallenge in Progressive Glioblastoma: The DIRECTOR Trial
- (2015) M. Weller et al. CLINICAL CANCER RESEARCH
- Outcome-based determination of optimal pyrosequencing assay for MGMT methylation detection in glioblastoma patients
- (2014) Véronique Quillien et al. JOURNAL OF NEURO-ONCOLOGY
- MGMT testing—the challenges for biomarker-based glioma treatment
- (2014) Wolfgang Wick et al. Nature Reviews Neurology
- Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics
- (2012) Y Kanda BONE MARROW TRANSPLANTATION
- Comparative assessment of 5 methods (methylation-specific polymerase chain reaction, methylight, pyrosequencing, methylation-sensitive high-resolution melting, and immunohistochemistry) to analyze O6-methylguanine-DNA-methyltranferase in a series of 100 g
- (2012) Véronique Quillien et al. CANCER
- A distinct region of the MGMT CpG island critical for transcriptional regulation is preferentially methylated in glioblastoma cells and xenografts
- (2011) Deborah S. Malley et al. ACTA NEUROPATHOLOGICA
- Annual Report to the Nation on the Status of Cancer, 1975-2007, Featuring Tumors of the Brain and Other Nervous System
- (2011) B. A. Kohler et al. JNCI-Journal of the National Cancer Institute
- Comprehensive Analysis of MGMT Promoter Methylation: Correlation with MGMT Expression and Clinical Response in GBM
- (2011) Nameeta Shah et al. PLoS One
- NOA-04 Randomized Phase III Trial of Sequential Radiochemotherapy of Anaplastic Glioma With Procarbazine, Lomustine, and Vincristine or Temozolomide
- (2009) Wolfgang Wick et al. JOURNAL OF CLINICAL ONCOLOGY
- Identification of regions correlating MGMT promoter methylation and gene expression in glioblastomas
- (2009) Sibille Everhard et al. NEURO-ONCOLOGY
- Malignant Gliomas in Adults
- (2008) Patrick Y. Wen et al. NEW ENGLAND JOURNAL OF MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now